IDH2
Isocitrate dehydrogenase [NADP], mitochondrial
Also known as: IDH-2, IDHP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48735
- Gene
- IDH2
- Ensembl
- ENSG00000182054
- Chromosome
- 15
- Canonical length
- 452 aa
- Protein class
- Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
452 residues, UniProt reviewed canonical sequence.
>P48735|IDH2
1 MAGYLRVVRS LCRASGSRPA WAPAALTAPT SQEQPRRHYA DKRIKVAKPV VEMDGDEMTR
61 IIWQFIKEKL ILPHVDIQLK YFDLGLPNRD QTDDQVTIDS ALATQKYSVA VKCATITPDE
121 ARVEEFKLKK MWKSPNGTIR NILGGTVFRE PIICKNIPRL VPGWTKPITI GRHAHGDQYK
181 ATDFVADRAG TFKMVFTPKD GSGVKEWEVY NFPAGGVGMG MYNTDESISG FAHSCFQYAI
241 QKKWPLYMST KNTILKAYDG RFKDIFQEIF DKHYKTDFDK NKIWYEHRLI DDMVAQVLKS
301 SGGFVWACKN YDGDVQSDIL AQGFGSLGLM TSVLVCPDGK TIEAEAAHGT VTRHYREHQK
361 GRPTSTNPIA SIFAWTRGLE HRGKLDGNQD LIRFAQMLEK VCVETVESGA MTKDLAGCIH
421 GLSNVKLNEH FLNTTDFLDT IKSNLDRALG RQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IDH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 1,504 nTPM
Expression across tissuesHPA
Tissue
- tongue: 1,504 nTPM
- skeletal muscle: 1,220 nTPM
- heart muscle: 462 nTPM
- liver: 251 nTPM
- kidney: 181 nTPM
- stomach: 168 nTPM
Single-cell type
- parietal cells: 1,126 nCPM
- cytotrophoblasts: 989 nCPM
- extravillous trophoblasts: 855 nCPM
- syncytiotrophoblasts: 766 nCPM
- migrating cytotrophoblasts: 573 nCPM
- paneth cells: 437 nCPM
Immune cell
- non-classical monocyte: 254 nTPM
- intermediate monocyte: 199 nTPM
- total PBMC: 163 nTPM
- myeloid DC: 137 nTPM
- memory CD8 T-cell: 120 nTPM
- classical monocyte: 113 nTPM
Brain region
- choroid plexus: 145 nTPM
- thalamus: 138 nTPM
- basal ganglia: 125 nTPM
- medulla oblongata: 115 nTPM
- midbrain: 112 nTPM
- cerebellum: 104 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IDH2.
Disease | AllUniProt
Conditions IDH2 is implicated in, by any mechanism.
- D-2-hydroxyglutaric aciduria 2 (D2HGA2) MIM:613657
- Glioma (GLM) MIM:137800
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 292 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- D-2-hydroxyglutaric aciduria 2
- Neoplasm
- Inborn genetic diseases
- IDH2-related mitochondrial disease
- Maffucci syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.88
- gnomAD missense Z
- 1.34
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 2-oxoglutarate metabolic process
- carbohydrate metabolic process
- glyoxylate cycle
- isocitrate metabolic process
- NADP+ biosynthetic process
- NADP+ metabolic process
- negative regulation of glial cell migration
- negative regulation of glial cell proliferation
- negative regulation of matrix metallopeptidase secretion
- tricarboxylic acid cycle
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IDH2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IDH2 as an antibody target. Whether an autoantibody or antibody against IDH2 could matter depends on whether native IDH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IDH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IDH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...